S. Marui et al., Mutations in the type II 3 beta-hydroxysteroid dehydrogenase (HSD3B2) genecan cause premature pubarche in girls, CLIN ENDOCR, 52(1), 2000, pp. 67-75
OBJECTIVE Most previous studies have failed to demonstrate any mutations in
the type II 3 beta hydroxysteroid dehydrogenase (HSD3B2) gene in patients
satisfying the hormonal criteria of nonclassic 3 beta-hydroxysteroid dehydr
ogenase deficiency, suggesting that a mutant 3 beta-hydroxysteroid dehydrog
enase protein is not the cause of this disorder. We screened the HSD3B2 gen
e for mutations in girls with premature pubarche and a hormonal diagnosis o
f 3 beta-hydroxysteroid dehydrogenase deficiency.
DESIGN From 30 girls with premature pubarche, we selected 9 whose ACTH-stim
ulated 17-hydroxypregnenolone levels were elevated (greater than or equal t
o 6 SD) and screened the HSD3B2 gene for mutations.
MEASUREMENTS All patients were submitted to a standard ACTH stimulation tes
t. Serum steroids were measured and compared to the mean level of pubertal
stage matched control subjects. The four exons and exon-intron boundaries o
f the HSD3B2 gene were amplified by polymerase chain reaction and screened
for mutations by denaturing gradient gel electrophoresis. The fragments wit
h abnormal migration on denaturing gradient gel electrophoresis were direct
ly sequenced.
RESULTS A homozygous T259M mutation was identified in one girl and a new co
mpound heterozygous G129R/P222H mutation was identified in two sisters. The
highest ACTH-stimulated 17-hydroxypregnenolone levels, 147, 339 and 351 nm
ol/l, were found in those patients with mutations in the HSD3B2 gene. In th
e patients without mutations, ACTH-stimulated 17-hydroxypregnenolone ranged
from 48 to 111 nmol/l. ACTH-stimulated dehydroepiandrosterone levels had a
n overlap among the girls with and without mutations and the normal control
s.
CONCLUSIONS Premature pubarche can be caused by mutations in the type II 3
beta hydroxysteroid dehydrogenase gene.